Metal-catalysed radical cyclisations leading to N-heterocycles: New approaches to gabapentin and pulchellalactam

Tetrahedron

Volumn 59, Issue 33, 2003, Pages 6221-6231

  Bryans, Justin S ^a   Chessum, Nicola E A ^b   Huther, Nathalie ^b   Parsons, Andrew F ^b   Ghelfi, Franco ^c  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Amino acids; Cyclisations; Nitrogen heterocycles; Radical reactions

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; HETEROCYCLIC COMPOUND; METAL; PULCHELLALACTAM; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CYCLIZATION; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY;

EID: 0042704956     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(03)01030-5     Document Type: Article

References (44)

1. (a) Bowman W.R., Fletcher A.J., Potts B.S. J. Chem. Soc., Perkin Trans. 1. 2002;2747.
2. (b) Parsons A.F. An Introduction to Free Radical Chemistry. 2000;Blackwell Science, Oxford.
3. (c) Galeazzi R., Mobbili G., Orena M., Rossetti M. Targets Heterocycl. Syst. 1:1997;355.
4. (a) Clark A.J. Chem. Soc. Rev. 31:2002;1.
5. (b) Iqbal J., Bhatia B., Nayyar N.K. Chem. Rev. 94:1994;519.
6. See for example: (a) Ghelfi F., Parsons A.F. J. Org. Chem. 65:2000;6249 (b) Ghelfi F., Bellesia F., Forti L., Ghirardini G., Grandi R., Libertini E., Montemaggi M.C., Pagnoni U.M., Pinetti A., De Buyck L., Parsons A.F. Tetrahedron. 55:1999;5839 (c) Ghelfi F., Ghirardini G., Libertini E., Forti L., Pagnoni U.M. Tetrahedron Lett. 40:1999;8595 (d) Clark A.J., Battle G.M., Bridge A. Tetrahedron Lett. 42:2001;4409.
7. See for example: (a) Ghelfi F., Parsons A.F. J. Org. Chem. 65:2000;6249 (b) Ghelfi F., Bellesia F., Forti L., Ghirardini G., Grandi R., Libertini E., Montemaggi M.C., Pagnoni U.M., Pinetti A., De Buyck L., Parsons A.F. Tetrahedron. 55:1999;5839 (c) Ghelfi F., Ghirardini G., Libertini E., Forti L., Pagnoni U.M. Tetrahedron Lett. 40:1999;8595 (d) Clark A.J., Battle G.M., Bridge A. Tetrahedron Lett. 42:2001;4409.
8. See for example: (a) Ghelfi F., Parsons A.F. J. Org. Chem. 65:2000;6249 (b) Ghelfi F., Bellesia F., Forti L., Ghirardini G., Grandi R., Libertini E., Montemaggi M.C., Pagnoni U.M., Pinetti A., De Buyck L., Parsons A.F. Tetrahedron. 55:1999;5839 (c) Ghelfi F., Ghirardini G., Libertini E., Forti L., Pagnoni U.M. Tetrahedron Lett. 40:1999;8595 (d) Clark A.J., Battle G.M., Bridge A. Tetrahedron Lett. 42:2001;4409.
9. See for example: (a) Ghelfi F., Parsons A.F. J. Org. Chem. 65:2000;6249 (b) Ghelfi F., Bellesia F., Forti L., Ghirardini G., Grandi R., Libertini E., Montemaggi M.C., Pagnoni U.M., Pinetti A., De Buyck L., Parsons A.F. Tetrahedron. 55:1999;5839 (c) Ghelfi F., Ghirardini G., Libertini E., Forti L., Pagnoni U.M. Tetrahedron Lett. 40:1999;8595 (d) Clark A.J., Battle G.M., Bridge A. Tetrahedron Lett. 42:2001;4409.
10. For a review see: (a) Ishibashi H., Sato T., Ikeda M. Synthesis. 2002;695 (b) Chatgilialoglu C., Ferreri C., Guerra M., Timokhin V., Froudakis G., Gimisis T. J. Am. Chem. Soc. 124:2002;10765.
11. For a review see: (a) Ishibashi H., Sato T., Ikeda M. Synthesis. 2002;695 (b) Chatgilialoglu C., Ferreri C., Guerra M., Timokhin V., Froudakis G., Gimisis T. J. Am. Chem. Soc. 124:2002;10765.
12. (a) Parsons A.F.C.R. Acad. Sci. Sér. IIc: Chim. 4:2001;391.
13. (b) Bryans J.S., Chessum N.E.A., Parsons A.F., Ghelfi F. Tetrahedron Lett. 42:2001;2901.
14. (c) Clark A.J., Dell C.P., McDonagh J.P.C.R. Acad. Sci. Sér. IIc: Chim. 4:2001;1.
15. Taylor C.P. Neurology. 44:1994;510.
16. Sutton K.G., Snutch T.P. Drug Dev. Res. 54:2002;167.
17. Bryans, J. S.; Morrell, A. I. Int. Pat. Appl. WO 99/14184, 1999; Chem. Abstr., 1999, 130, 223583.
18. (a) Bryans J.S., Davies N., Gee N.S., Dissanayake V.U.K., Ratcliffe G.S., Horwell D.C., Kneen C.O., Morrell A.I., Oles R.J., O'Toole J.C., Perkins G.M., Singh L., Suman-Chauhan N., O'Neill J.A. J. Med. Chem. 41:1998;1838.
19. (b) Receveur J.-M., Bryans J.S., Field M.J., Singh L., Horwell D.C. Bioorg. Med. Chem. Lett. 9:1999;2329.
20. (c) Bryans J.S., Horwell D.C., Ratcliffe G.S., Receveur J.-M., Rubin J.R. Bioorg. Med. Chem. 7:1999;715.
21. (d) Griffiths G., Mettler H., Mills L.S., Previdoli F. Helv. Chim. Acta. 74:1991;309.
22. iPrOH see: Cassayre J., Quiclet-Sire B., Saunier J.-B., Zard S.Z. Tetrahedron. 54:1998;1029.
23. 3 in toluene gave 2-benzyl-4,4-dichloro-1-hydroxy-2-azaspiro[4.5]decan-3-one in only 20% yield (together with β-lactam products in 28% yield).
24. Copper(I) hydride can be generated from copper(I) chloride and tributyltin hydride: Tanaka H., Yamaguchi Y., Sumida S.-I., Kuroboshi M., Mochizuki M., Torii S. J. Chem. Soc., Perkin Trans. 1. 1999;3463.
25. 3SiH see: Quirante J., Escolano C., Diaba F., Bonjoch J. J. Chem. Soc., Perkin Trans. 1. 1999;1157.
26. Auerbach J., Zamore M., Weinreb S.M. J. Org. Chem. 41:1976;725.
27. 3SnH (added over 5 h). In addition to the simple reduced product, this gave products derived from radical fragmentation and radical fragmentation followed by 5-endo-trig cyclisation.
28. Casarini M.E., Ghelfi F., Libertini E., Pagnoni U.M., Parsons A.F. Tetrahedron. 58:2002;7925.
29. For related cyclisations see: (a) Nagashima H., Ara K.-I., Wakamatsu H., Itoh K. J. Chem. Soc., Chem. Commun. 1985;518 (b) Jolly R.S., Livinghouse T. J. Am. Chem. Soc. 110:1988;7536 (c) Boivin J., Yousfi M., Zard S.Z. Tetrahedron Lett. 35:1994;5629 (d) Ikeda M., Teranishi H., Nozaki K., Ishibashi H. J. Chem. Soc., Perkin Trans. 1. 1998;1691.
30. For related cyclisations see: (a) Nagashima H., Ara K.-I., Wakamatsu H., Itoh K. J. Chem. Soc., Chem. Commun. 1985;518 (b) Jolly R.S., Livinghouse T. J. Am. Chem. Soc. 110:1988;7536 (c) Boivin J., Yousfi M., Zard S.Z. Tetrahedron Lett. 35:1994;5629 (d) Ikeda M., Teranishi H., Nozaki K., Ishibashi H. J. Chem. Soc., Perkin Trans. 1. 1998;1691.
31. For related cyclisations see: (a) Nagashima H., Ara K.-I., Wakamatsu H., Itoh K. J. Chem. Soc., Chem. Commun. 1985;518 (b) Jolly R.S., Livinghouse T. J. Am. Chem. Soc. 110:1988;7536 (c) Boivin J., Yousfi M., Zard S.Z. Tetrahedron Lett. 35:1994;5629 (d) Ikeda M., Teranishi H., Nozaki K., Ishibashi H. J. Chem. Soc., Perkin Trans. 1. 1998;1691.
32. For related cyclisations see: (a) Nagashima H., Ara K.-I., Wakamatsu H., Itoh K. J. Chem. Soc., Chem. Commun. 1985;518 (b) Jolly R.S., Livinghouse T. J. Am. Chem. Soc. 110:1988;7536 (c) Boivin J., Yousfi M., Zard S.Z. Tetrahedron Lett. 35:1994;5629 (d) Ikeda M., Teranishi H., Nozaki K., Ishibashi H. J. Chem. Soc., Perkin Trans. 1. 1998;1691.
33. (a) Fernández R., Ferrete A., Lassaletta J.M., Llera J.M., Martin-Zamora E. Angew. Chem. Int. Ed. 41:2002;831.
34. (b) Fernández R., Ferrete A., Lassaletta J.M., Llera J.M., Monge A. Angew. Chem. Int. Ed. 39:2000;2893.
35. Ghelfi F., Stevens C.V., De Buyck L., Laureyn I., Van Meenen E., Rogge T.M., Nikitin K.V., Grandi R., Libertini E., Pagnoni U.M., Schenetti L. Tetrahedron. 59:2003;1147.
36. Alvi K.A., Casey A., Nair B.G. J. Antibiot. 51:1997;515.
37. (a) Davies D.T., Kapur N., Parsons A.F. Tetrahedron Lett. 40:1999;8615.
38. (b) Davies D.T., Kapur N., Parsons A.F. Tetrahedron. 56:2000;3941.
39. (a) Paquette L.A., Macdonald D., Anderson L.G. J. Am. Chem. Soc. 112:1990;9292.
40. (b) Smith A.B., Rano T.A., Chida N., Sulikowski G.A., Wood J.L. J. Am. Chem. Soc. 114:1992;8008.
41. (a) Fetter J., Lampert K., Kajtár-Peredy M., Simig G. J. Chem. Soc., Perkin Trans. 1. 1988;1135
42. (b) Shiozaki M., Ishida N., Hiraoka T., Maruyama H. Tetrahedron. 40:1984;1795.
43. Li W.-R., Tsai Lin S., Hsu N.-M., Chern M.-S. J. Org. Chem. 67:2002;4702.
44. Ali M.H., Wiggin C.J. Synth. Commun. 31:2001;3383.